Medscape has reported the results of its 2020 annual physician survey, This year rheumatologists (60%), general surgeons (60%), public health and preventive medicine physicians, and allergists/immunologists are the "happiest" outside of work compared to other specialists, according to Medscape.
Lowest in happiness were internal medicine, critical care and neurology (44-48%).
Lancet Rheumatology has reported the results of a multicenter follow-up study of systemic lupus erythematosus (SLE) patients showing that organ damange is linked to glucocorticoid use, independent of clinical or serological disease activity.
Dr. John Cush RheumNow
6 years 9 months ago
Dr Kevin Winthrop has published claims analyses showing nontuberculous mycobacterial infections are increasing- from 3.13 to 4.73/100,000PY & prevalence from 6.78 to 11.7/100,000PYs (from 2008 to 2015), esp in women & elderly https://t.co/IuXQACC9eE
Dr. John Cush RheumNow
6 years 9 months ago
128 pts w/ Breast Cancer were evaluated for rheumatic complaints. Ultimately 1/3 developed an inflammatory rheumatic disease; most common being RA (8%), Sjogrens (6%) & PsA (5%). Arthralgias were more common with aromatase inhibitor use. https://t.co/d9CqWfRrXD
Dr. John Cush RheumNow
6 years 9 months ago
RheumNow Podcast is up! Oral Vs IV Abx, Drugs for Dactylitis/Enthesitis, Arterial embolization for OA; watch here>> https://t.co/GkpOmT4uSZ or Listen on Apple podcasts or here >> https://t.co/a2KtwRjkOY
Dr. John Cush RheumNow
6 years 9 months ago
Among 1827 SLE pts, 52.3% had neuropsychiatric (NP) events attributed to SLE. In first 2 years the relative risk for SLE NP events was 6.16. Mortality was higher with NP events attributed to SLE (16%) versus no NPSLE events (6%) https://t.co/uCx5Uf9kJj
Statin-induced myositis, often with anti-HMGCR autoantibodies can be difficult to manage, Arthritis Research & Therapy yhas published the experience of 55 patient with HMGCR myopathy, demonstrating that while steroid management may be reasonable in select patients, the use of triple steroid/IVIG/SSI was very efficacious in induction.
Dr. John Cush RheumNow
6 years 9 months ago
UK study of 2701 Early arthritis pts Dx in 3 different eras finds that from those dx in 2010, 59% were estimated to reach low disease activity compared with 48% with diagnosis in 2002 and 32% with diagnosis in 1990. https://t.co/rn2cYLID6V
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. The podcast covers: best therapies for dactylitis and enthesitis; we have a new knockout for knee pain in OA; and are you on the naughty or nice list when it comes to the new ACR-AF guidelines for arthritis? This and more. Tune in.
A group of Western Australian clinicians have set out to assess current practices and proved guidance recommendations for high-quality care for the most common musculoskeletal (MSK) pain scenarios encountered by clinicians in emergency and primary care. They have promulgated 11 high-quality clinical practice guidelines (CPGs).
Dr. John Cush RheumNow
6 years 9 months ago
JAMA Case challenge: 61yoM with seronegative RA x yrs (rx w/ MTX and biologics) develops intermittent fever (38C), asymmetric polyarthralgias, & 50 lb Weight Loss, CRP 7.7mg/L. No response to TCZ and developed diarrhea. What do you do next? https://t.co/QkGca1qp9r
A study from the Journal of Vascular and Interventional Radiology has shown that knee pain secondary to osteoarthritis (OA) may be effectively treated by selective vascular interruption (embolization) showing efficacy and safety in a small pilot trial.
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW lecturing on PSS skin disease Tx algorithm published in A&R. CTX has clearly dropped off https://t.co/l4fj8UzrtU
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW lecturing on PSS. Other options for refractory dz include IVIG, RTX, TCZ, ABA and uVA1 therapy https://t.co/sn2sqXTFSN

